Excitotoxic degeneration of hypothalamic orexin neurons in slice culture

Hiroshi Katsuki1, Akinori Akaike

  • 1Department of Pharmacology, Graduate School of Pharmaceutical Sciences, Kyoto University, Kyoto 606-8501, Sakyo, Japan.

Neurobiology of Disease
|January 31, 2004
PubMed

Insights

Narcolepsy may stem from the loss of orexin neurons. Researchers found that quinolinic acid, an excitotoxin, selectively damages these neurons via NMDA receptors, offering insights into narcolepsy mechanisms.

Area of Science:

  • Neuroscience
  • Sleep Medicine
  • Neurobiology

Background:

  • Narcolepsy is linked to the loss of hypothalamic orexin (hypocretin)-containing neurons.
  • The precise mechanisms driving this selective neuronal loss remain unclear.

Purpose of the Study:

  • To investigate the vulnerability of orexin neurons to excitotoxic insults.
  • To identify potential endogenous excitotoxins and mechanisms involved in orexin neuron loss.

Main Methods:

  • Organotypic rat hypothalamic slice cultures were used.
  • Cultures were exposed to N-methyl-D-aspartate (NMDA), kainic acid, and quinolinic acid.
  • Effects on orexin and melanin-concentrating hormone (MCH) neurons were assessed.
  • Involvement of NMDA receptors and poly(ADP-ribose) polymerases was examined.

Main Results:

  • N-methyl-D-aspartate (NMDA) incubation significantly reduced orexin neurons, while MCH neurons were spared.
  • Orexin neurons showed greater resistance to kainic acid compared to MCH neurons.
  • Quinolinic acid selectively decreased orexin neurons by activating NMDA receptors.
  • An inhibitor of poly(ADP-ribose) polymerases prevented quinolinic acid-induced orexin neuron loss.

Conclusions:

  • NMDA receptor-mediated injury is a potential mechanism for the selective loss of orexin neurons.
  • This excitotoxic pathway may contribute to the neuropathology observed in narcolepsy.
  • Quinolinic acid emerges as a potential endogenous excitotoxin implicated in orexin neuron degeneration.

Related Concept Videos